Paydirt
Insider filing · KNSA

Mark Ragosa sold $1.7M of Kiniksa Pharmaceuticals International (KNSA)

Executed Mar 9, disclosed Mar 11, 2 days later.

Value, as filed
$1.7M
36,722 sh across 2 lots
Executed
Mar 9
the trade date, as filed
Disclosed
Mar 11
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
MR Mark Ragosa CHIEF FINANCIAL OFFICER profile →

Mark Ragosa (CHIEF FINANCIAL OFFICER) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $1.8M of KNSA (42,841 sh × $41.49, as filed), executed Dec 8 2025.

The name
KNSA Kiniksa Pharmaceuticals International, plc KNSA · Healthcare · 68 filings in 24 months ticker →

Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Mark Ragosa in KNSA
KNSASALE Kiniksa Pharmaceuticals International, plc $772K
17,845 sh across 2 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $503K
12,000 sh × $41.89
Exec Jan 8
Filed Jan 9 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $1.8M
42,841 sh × $41.49
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $815K
19,900 sh × $40.94
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $621K
18,889 sh × $32.89
Exec Aug 4 2025
Filed Aug 6 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $527K
18,299 sh × $28.80
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $2.3M
88,395 sh across 3 lots
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $368K
15,944 sh × $23.11
Exec Mar 20 2025
Filed Mar 24 2025 · 5:30 PM ET